Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Remedy's decision to discontinue early conceptualization Kestrel brings more focus to strategy

By Atte RiikolaAnalyst
2024-05-07 12:39
Remedy Entertainment

Translation: Original comment published in Finnish on 5/7/2024 at 12:39 pm EEST.

Remedy announced on Tuesday that it has decided to end its game project with Tencent, codenamed Kestrel. Kestrel had a small team working on the early conceptualization stage of the premium co-op multiplayer. The game was co-funded and to be co-published with Tencent. The project began in November 2023 as a relaunch of the previous Vanguard project.

According to Remedy, the decision to exit Kestrel will allow the company to focus more on other games in its portfolio, where experienced developers will now be transferred from Kestrel. In addition, the planned investments for Kestrel will be eliminated and Remedy's overall hiring needs will be reduced.

The future is increasingly built around Alan Wake and Control

We welcome Remedy's decision, as Kestrel (and previously Vanguard) were projects that were outside the company's core competencies. The company can now focus on growing the game brands it owns (Alan Wake and Control), where we see much better long-term potential from a risk/reward perspective. At the same time, the Max Payne subcontracting project balances the risks and develops Remedy's capabilities to create similar action games. A more limited number of game projects should also make it easier to move them forward on time and with the highest quality.

In our view, Kestrel's discontinuation may also indicate that the company is working toward self-publishing Condor and/or Control 2, which would require significant investment and additional funding in the coming years. Nor would we be surprised if Tencent, which just increased its stake in Remedy to 14.8%, was willing to fund these projects instead of Kestrel.

Our forecasts will change once the decisions on the Control games have been taken

As we stated in our update following the Q1 report, Remedy's decision to self-publish or choose a publishing partner for Control games will result in changes to our current forecasts. Killing off Kestrel will lower our development fee assumptions in the medium term and our projections also assumed small royalties from the game from 2029 onwards. At this point, the 2030 royalty rate is very low, of course, but a key factor in expectations will be whether Remedy decides to go the self-publishing route for Control games. As for Alan Wake, the fate of future games is still entirely in the hands of the company, as the publishing deal with Epic only covered Alan Wake 2 and Alan Wake Remastered.

Remedy Entertainment

18.82EUR2024-05-06 18:00
20EURTarget price
Accumulate
Recommendation updated:2024-04-29

Remedy Entertainment is a game developer. The business is primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games developed by the company include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and utility technology that powers many of the games. The company was founded in 1995 and has its headquarters in Espoo.

Read more on company page

Key Estimate Figures2024-04-29

202324e25e
202324e25e
Revenue33.948.659.0
growth-%-22.2 %43.3 %21.3 %
EBIT (adj.)-28.6-8.8-3.1
EBIT-% (adj.)-84.4 %-18.0 %-5.2 %
EPS (adj.)-1.68-0.52-0.18
Dividend0.000.000.00
Dividend %
P/E (adj.)---
EV/EBITDA--80.9
Forum discussions
Här är analytikerns kommentarer om det mycket intressanta finska spelbolagets resultat för första kvartalet. Inderes Remedy Q1'25 snabbkommentar...
5/1/2025, 9:55 AM
by börsen84
0
Remedys resultat för det första kvartalet förväntas ligga i linje med föregående kvartal – fortfarande förlustbringande, men i en positiv riktning...
4/23/2025, 10:28 PM
by börsen84
0
Remedys resultat överträffade förväntningarna, och spelprojekten fortskrider enligt plan. Bolaget förväntar sig att rörelseresultatet blir positivt...
2/13/2025, 5:33 PM
by börsen84
0
Remedy publicerar sin Q4-rapport den 12 februari kl. 9. Det förväntas vara årets svagaste kvartal, men fokus ligger redan på tillväxt. AW2 har...
2/5/2025, 9:00 PM
by börsen84
0
Inderes upprepar sin Köp-rekommendation och riktkursen på 19 euro för Remedy. Remedy har visat sin förmåga att skapa högkvalitativa spel, men...
12/18/2024, 2:24 PM
by börsen84
0
Jag har läst några investerares tankar och baserat på detta har jag skrivit ner mina reflektioner. Jag är själv ingen expert på detta företag...
11/30/2024, 11:43 AM
by börsen84
0
Remedy strävar efter hållbar tillväxt och planerar att släppa ett nytt spel årligen under perioden 2025–2030. Företaget siktar på att fördubbla...
11/20/2024, 6:04 PM
by börsen84
0
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.